Page last updated: 2024-10-15

oxetanocin g

Description

oxetanocin G: inhibits human cytomegalovirus replication; structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID135433622
SCHEMBL ID3417410
MeSH IDM0160839

Synonyms (14)

Synonym
oxetanocin g
113269-46-8
9-(2-deoxy-2-hydroxymethyl-.beta.-d-erythro-oxetanosyl)guanosine
6h-purin-6-one, 2-amino-9-[(2r,3r,4s)-3,4-bis(hydroxymethyl)-2-oxetanyl]-1,9-dihydro-
2-amino-9-[(2r,3r,4s)-3,4-bis(hydroxymethyl)oxetan-2-yl]-1h-purin-6-one
oxt. g
2-amino-9-[(2r,3r,4s)-3,4-bis(hydroxymethyl)oxetan-2-yl]-3h-purin-6-one
oxt-g
6h-purin-6-one, 2-amino-9-(3,4-bis(hydroxymethyl)-2-oxetanyl)-1,9-dihydro-, (2r-(2alpha,3beta,4alpha))-
SCHEMBL3417410
DTXSID80150335
BCSLVBZWCFTDPK-UDJQAZALSA-N
2-amino-9-((2r,3r,4s)-3,4-bis(hydroxymethyl)oxetan-2-yl)-1h-purin-6(9h)-one
2-amino-9-[(2r,3r,4s)-3,4-bis(hydroxymethyl)oxetan-2-yl]-6,9-dihydro-1h-purin-6-one
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (16)

TimeframeStudies, This Drug (%)All Drugs %
pre-19903 (18.75)18.7374
1990's12 (75.00)18.2507
2000's1 (6.25)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials1 (6.25%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other15 (93.75%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]